Posted on 16 May 2011
Tags: big pharma, India, partnering, Sanofi
India's biotech companies are beginning to make their mark in the antibody development field. Sanofi has inked a $613m development pact with Glenmark Pharmaceuticals...
Read the full release on the Sanofi/Glenmark deal
Click here to cancel reply.
Email (will not be published) (required)
Your website (optional)
© 2020 Wildwood Ventures Ltd.